187 related articles for article (PubMed ID: 29877216)
1. Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis.
Goda K; Saito K; Muta K; Kobayashi A; Saito Y; Sugai S
J Toxicol Sci; 2018; 43(6):395-405. PubMed ID: 29877216
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis.
Saito K; Goda K; Kobayashi A; Yamada N; Maekawa K; Saito Y; Sugai S
J Appl Toxicol; 2017 Aug; 37(8):943-953. PubMed ID: 28138993
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.
Tang W; Borel AG; Fujimiya T; Abbott FS
Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
Tong V; Teng XW; Chang TK; Abbott FS
Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles of murine fatty liver induced by the administration of valproic acid.
Lee MH; Hong I; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2007 Apr; 220(1):45-59. PubMed ID: 17292431
[TBL] [Abstract][Full Text] [Related]
6. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylcholine (18:0/20:4), a potential biomarker to predict ethionamide-induced hepatic steatosis in rats.
Muta K; Saito K; Kemmochi Y; Masuyama T; Kobayashi A; Saito Y; Sugai S
J Appl Toxicol; 2022 Sep; 42(9):1533-1547. PubMed ID: 35315511
[TBL] [Abstract][Full Text] [Related]
8. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
[TBL] [Abstract][Full Text] [Related]
9. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
Löscher W; Wahnschaffe U; Hönack D; Wittfoht W; Nau H
Epilepsy Res; 1992 Dec; 13(3):187-98. PubMed ID: 1493781
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.
Zhang LF; Liu LS; Chu XM; Xie H; Cao LJ; Guo C; A JY; Cao B; Li MJ; Wang GJ; Hao HP
Acta Pharmacol Sin; 2014 Mar; 35(3):363-72. PubMed ID: 24442146
[TBL] [Abstract][Full Text] [Related]
11. The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats.
Tong V; Chang TK; Chen J; Abbott FS
Free Radic Biol Med; 2003 Jun; 34(11):1435-46. PubMed ID: 12757854
[TBL] [Abstract][Full Text] [Related]
12. Age-related differences in susceptibility to toxic effects of valproic acid in rats.
Espandiari P; Zhang J; Schnackenberg LK; Miller TJ; Knapton A; Herman EH; Beger RD; Hanig JP
J Appl Toxicol; 2008 Jul; 28(5):628-37. PubMed ID: 17994530
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of valproic acid in isolated rat liver mitochondria.
Jafarian I; Eskandari MR; Mashayekhi V; Ahadpour M; Hosseini MJ
Toxicol Mech Methods; 2013 Oct; 23(8):617-23. PubMed ID: 23819490
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
Ma L; Wang Y; Chen X; Zhao L; Guo Y
Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
[TBL] [Abstract][Full Text] [Related]
15. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies.
Kesterson JW; Granneman GR; Machinist JM
Hepatology; 1984; 4(6):1143-52. PubMed ID: 6437960
[TBL] [Abstract][Full Text] [Related]
16. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication.
Löscher W; Nau H; Wahnschaffe U; Hönack D; Rundfeldt C; Wittfoht W; Bojic U
Epilepsy Res; 1993 Jun; 15(2):113-31. PubMed ID: 8370349
[TBL] [Abstract][Full Text] [Related]
17. The effects of vitamin B6 on lens antioxidant system in valproic acid-administered rats.
Tunali S
Hum Exp Toxicol; 2014 Jun; 33(6):623-8. PubMed ID: 24107455
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models.
Vitins AP; Kienhuis AS; Speksnijder EN; Roodbergen M; Luijten M; van der Ven LT
Arch Toxicol; 2014 Aug; 88(8):1573-88. PubMed ID: 24535564
[TBL] [Abstract][Full Text] [Related]
19. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
[TBL] [Abstract][Full Text] [Related]
20. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis.
Bai X; Hong W; Cai P; Chen Y; Xu C; Cao D; Yu W; Zhao Z; Huang M; Jin J
Toxicol Appl Pharmacol; 2017 Jun; 324():12-25. PubMed ID: 28366540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
